Measuring quality of life impairment in skeletal muscle channelopathies. - Wikidata - wikimedia - TriplyDB

Measuring quality of life impairment in skeletal muscle channelopathies.

Measuring quality of life impairment in skeletal muscle channelopathies.

http://www.wikidata.org/entity/Q36382734

about

Muscle channelopathies: the nondystrophic myotonias and periodic paralyses.Measuring quality of life in muscular dystrophy.Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol.Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis.Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.Sleep-Wake Cycle and Daytime Sleepiness in the Myotonic Dystrophies A systematic review of patient-reported outcomes in patients with cutaneous lupus erythematosus.Nondystrophic myotonia: challenges and future directions.Review of the Diagnosis and Treatment of Periodic Paralysis.Progress in European neurology 2012-2013.The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study.Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy.Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy

P2860

Q34523030-5104F7D0-5056-4FE3-855B-6359F866C81B Q35154897-B96B1381-F256-41C0-9933-B21FF4FDEDCE Q35532209-BBE71009-693B-4926-B52A-97F8C013EEF1 Q36765372-18E0A562-E28B-42BD-B18C-14588679F407 Q36796484-C29F63DC-80B5-4EC3-A7F7-AEA49CB05565 Q36953843-F10380E4-7D0A-4805-AA1B-9B5E69078A5F Q38575770-ADDF3722-11EB-4AEB-A454-E307B1C43D82 Q38896851-9EA8CA46-20E7-4C5A-B887-D83C73181A2E Q39289663-AD6957A2-0A66-436E-85C2-E26B505BB786 Q45957826-D1D85AEC-E0E6-4A8F-A499-264B87C1E357 Q46040914-7E29CE0D-6622-4D91-BAB7-0C74E0B96B7D Q48011157-2023328D-7338-4BE2-8647-B20A7BF7992C Q48153881-ECFCA7D9-A91A-48DF-B135-5F113E368A8D Q57300169-B2823512-53AD-4532-AD75-45AFD836ECC8

P2860

Measuring quality of life impairment in skeletal muscle channelopathies.

http://www.wikidata.org/entity/Q36382734

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Measuring quality of life impairment in skeletal muscle channelopathies.

@ast

Measuring quality of life impairment in skeletal muscle channelopathies.

@en

type

label

Measuring quality of life impairment in skeletal muscle channelopathies.

@ast

Measuring quality of life impairment in skeletal muscle channelopathies.

@en

prefLabel

Measuring quality of life impairment in skeletal muscle channelopathies.

@ast

Measuring quality of life impairment in skeletal muscle channelopathies.

@en

P1433

Q36382734-8368B2C4-5D3B-40A6-88BC-9A38B62E0491

P1476

Q36382734-48268FD7-1252-44B5-9D63-DE370F41A182

P2093

Q36382734-04F16C38-B016-482D-AD25-657596857FC6

Q36382734-38C0AB13-156D-40BB-8943-F8C82558028C

Q36382734-60ADA659-E0BB-4735-BEE4-D8C9A8725964

Q36382734-63D24FC7-B007-4DB7-9CE3-E4B43910DAF3

Q36382734-CED65AA3-7305-4CEF-8042-401353BDDAEA

P2860

Q36382734-0C02462C-AE68-4F69-8C2A-6B86D32F01BC

Q36382734-1BC1C258-4019-47DD-BC1B-4EDFA3F86CD5

Q36382734-42976AE9-3064-45AD-8D8F-46BD4D3A8E66

Q36382734-4A6DDB20-148E-463F-B6F4-AE13704E38BF

Q36382734-5408E281-2FDE-4517-80D9-DB9A11394081

Q36382734-6ECA0F7A-9C89-4987-A232-C9B59D0E3CF3

Q36382734-83892A02-A059-4BA6-B18A-09FEA3CB368C

Q36382734-8BDA3261-ED0C-4173-AAB4-FD0117419BB7

Q36382734-A7119614-56A0-454E-951B-42B0C3D64D1A

Q36382734-B9C09CCF-C8E4-4F20-B1BD-D4C6D0A1D177

P304

Q36382734-42EE0DA9-FE2D-4F7A-9823-8DC8FFB07FBB

P31

Q36382734-FE623CF1-BC0B-4EFC-B2BA-A387647B3FC9

P356

Q36382734-44DEB0D9-A7CF-4576-8EAB-9DDF2EE096F5

P433

Q36382734-90AB5F77-B4D9-4DEC-9BA2-1B06A232913F

P478

Q36382734-281C9C73-7EE3-4413-8569-2E8410AB7FAC

P50

Q36382734-B2913725-8B8C-452D-B54E-2D5B8446110A

Q36382734-C78B500B-777A-4571-A9D6-DC6A498435F2

P577

Q36382734-8BE4A2C7-114D-4124-B27A-A41BC9FD3134

P5875

Q36382734-464D50E5-88BF-4600-B8F5-1E8FF3A0F7CB

P698

Q36382734-E99A90DE-E2F8-4EC8-9BC7-4CE70C761778

P921

Q36382734-BB48D06D-154A-4CCE-87C1-8BF1DA0D02E4

P932

Q36382734-5480A013-8242-4639-8206-F64DA92DE2F0

P356

J.1468-1331.2012.03751.X

P1433

European Journal of Neurology

P1476

Measuring quality of life impairment in skeletal muscle channelopathies

@en

P2093

C Ricci

http://www.w3.org/2001/XMLSchema#string

INQoL Group

http://www.w3.org/2001/XMLSchema#string

M Montanari

http://www.w3.org/2001/XMLSchema#string

M Rose

http://www.w3.org/2001/XMLSchema#string

V A Sansone

http://www.w3.org/2001/XMLSchema#string

P2860

Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A

Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

Management and treatment of Andersen-Tawil syndrome (ATS).

High disease impact of myotonic dystrophy type 2 on physical and mental functioning

The primary periodic paralyses: diagnosis, pathogenesis and treatment.

Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL).

Cerebral involvement in myotonic dystrophies.

Health status in non-dystrophic myotonias: close relation with pain and fatigue.

Novel insights into the pathomechanisms of skeletal muscle channelopathies.

P304

1470-1476

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1468-1331.2012.03751.X

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni Apolone

P577

2012-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235638279

http://www.w3.org/2001/XMLSchema#string

P698

22607270

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

P932

3492909

http://www.w3.org/2001/XMLSchema#string